Negative / Null Result ReportOpen accessMedicine· cited by 34

Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

Maxwell Akanbi; Chad J. Achenbach; Babafemi Taiwo; John Idoko; Agatha Ani; Yetunde Isa; Oche Agbaji; Christiana O Ukoli · 2017 · BMC Pulmonary Medicine

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Xpert MTB/Rif (Xpert) is described as a game changer in tuberculosis (TB) control. We evaluated the impact of Xpert on diagnosis, time to treatment, and treatment outcome among patients with HIV associated TB in Nigeria. METHODS: Adults with HIV being evaluated for pulmonary TB (PTB) were consecutively enrolled into the study cohort. At baseline, expectorated sputa were examined using Xpert and smear microscopy for Mycobacterium tuberculosis (MTB) and acid fast bacilli, respectively. Patients diagnosed with TB were followed-up until 6 months post TB diagnosis. TB was defined as spu

Abstract by Maxwell Akanbi; Chad J. Achenbach; Babafemi Taiwo; John Idoko; Agatha Ani; Yetunde Isa; Oche Agbaji; Christiana O Ukoli, BMC Pulmonary Medicine (2017) — licensed CC BY 4.0.

Read the full paper (open access)